Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Barry Ticho currently holds 19,059 shares of Stoke Therapeutics, Inc. (STOK), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Barry Ticho has been a net seller of STOK stock. They have purchased $0 and sold $4.6M worth of shares.
Barry Ticho's most recent insider trade was on Oct 1, 2026, when they sold 1,051 shares at $26.16 per share.
Barry Ticho serves as Executive at Stoke Therapeutics, Inc. (STOK). They have executed 79 insider transactions totaling $4.6M over their tenure at the company.
Barry Ticho holds the position of Executive at Stoke Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 6 years and currently hold a stake valued at $0.
Barry Ticho has shown a selling trading pattern, with $0 in total purchases and $4.6M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Barry Ticho was on Jun 3, 2024, when they sold $150.5K worth of STOK shares. This transaction involved 9,897 shares at $15.21 per share.
Barry Ticho currently owns 19,059 shares of Stoke Therapeutics, Inc. (STOK), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Barry Ticho's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Barry Ticho has 79 Form 4 filings on record as an insider at Stoke Therapeutics, Inc..
Set alerts for Barry Ticho and 40,000+ other insiders.